Unknown

Dataset Information

0

In vitro resistance selection and in vivo efficacy of morpholino oligomers against West Nile virus.


ABSTRACT: We characterize in vitro resistance to and demonstrate the in vivo efficacy of two antisense phosphorodiamidate morpholino oligomers (PMOs) against West Nile virus (WNV). Both PMOs were conjugated with an Arg-rich peptide. One peptide-conjugated PMO (PPMO) binds to the 5' terminus of the viral genome (5'-end PPMO); the other targets an essential 3' RNA element required for genome cyclization (3' conserved sequence I [3' CSI] PPMO). The 3' CSI PPMO displayed a broad spectrum of antiflavivirus activity, suppressing WNV, Japanese encephalitis virus, and St. Louis encephalitis virus, as demonstrated by reductions in viral titers of 3 to 5 logs in cell cultures, likely due to the absolute conservation of the 3' CSI PPMO-targeted sequences among these viruses. The selection and sequencing of PPMO-resistant WNV showed that the 5'-end-PPMO-resistant viruses contained two to three mismatches within the PPMO-binding site whereas the 3' CSI PPMO-resistant viruses accumulated mutations outside the PPMO-targeted region. The mutagenesis of a WNV infectious clone demonstrated that the mismatches within the PPMO-binding site were responsible for the 5'-end PPMO resistance. In contrast, a U insertion or a G deletion located within the 3'-terminal stem-loop of the viral genome was the determinant of the 3' CSI PPMO resistance. In a mouse model, both the 5'-end and 3' CSI PPMOs (administered at 100 or 200 microg/day) partially protected mice from WNV disease, with minimal to no PPMO-mediated toxicity. A higher treatment dose (300 microg/day) caused toxicity. Unconjugated PMOs (3 mg/day) showed neither efficacy nor toxicity, suggesting the importance of the peptide conjugate for efficacy. The results suggest that a modification of the peptide conjugate composition to reduce its toxicity yet maintain its ability to effectively deliver PMO into cells may improve PMO-mediated therapy.

SUBMITTER: Deas TS 

PROVIDER: S-EPMC1913242 | biostudies-literature | 2007 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

In vitro resistance selection and in vivo efficacy of morpholino oligomers against West Nile virus.

Deas Tia S TS   Bennett Corey J CJ   Jones Susan A SA   Tilgner Mark M   Ren Ping P   Behr Melissa J MJ   Stein David A DA   Iversen Patrick L PL   Kramer Laura D LD   Bernard Kristen A KA   Shi Pei-Yong PY  

Antimicrobial agents and chemotherapy 20070507 7


We characterize in vitro resistance to and demonstrate the in vivo efficacy of two antisense phosphorodiamidate morpholino oligomers (PMOs) against West Nile virus (WNV). Both PMOs were conjugated with an Arg-rich peptide. One peptide-conjugated PMO (PPMO) binds to the 5' terminus of the viral genome (5'-end PPMO); the other targets an essential 3' RNA element required for genome cyclization (3' conserved sequence I [3' CSI] PPMO). The 3' CSI PPMO displayed a broad spectrum of antiflavivirus act  ...[more]

Similar Datasets

| S-EPMC6251509 | biostudies-literature
| S-EPMC6719133 | biostudies-literature
| S-EPMC7349994 | biostudies-literature
| S-EPMC4200346 | biostudies-literature
| S-EPMC2267767 | biostudies-literature
| S-EPMC4766991 | biostudies-literature
| S-EPMC2694136 | biostudies-literature
| S-EPMC6963603 | biostudies-literature
| S-EPMC4864329 | biostudies-literature
| S-EPMC2844573 | biostudies-literature